Affymax Combi-Chem Efforts Yield "Hits" For Anemia, Obesity And Epilepsy
Executive Summary
Affymax' combinatorial chemistry endeavors have identified compound "hits" for at least five disease categories, Affymax Krypton Unit Director Jeffrey Sugarman, PhD, told the American Association of Pharmaceutical Scientists annual meeting in New Orleans Nov. 15.